Cerulean Pharma

Cerulean Pharma to cut staff, merge with San Diego biotech
Bizjournals.com
Mon, 03/20/17 - 11:25 pm
Cerulean Pharma
M&A
layoffs
Daré Bioscience
Key FDA Decisions and Trial Results Expected in October
24/7 Wall St
Tue, 10/4/16 - 10:07 am
FDA
clinical trials
Exelixis
cabozantinib
Cobimetinib
Celldex Therapeutics
CDX-011
Cerulean Pharma
CRLX101
Medivation
Xtandi
Palatin
bermelanotide
Rexahn
RX-3117
Anthera Pharmaceuticals
Key FDA Decisions and Trial Results Coming in the Next 2 Months
24/7 Wall St
Wed, 09/14/16 - 11:53 pm
FDA
clinical trials
Array Biopharma
binimetinib
Mast Therapeutics
Novavax
RSV F vaccine
Threshold Pharmaceuticals
tarloxotinib
Cerulean Pharma
Vertex Pharmaceuticals
Orkambi
Exelixis
cabozantinib
Cobimetinib
Medivation
Xtandi
Celldex
Key FDA Decisions and Trial Results Expected in October
24/7 Wall St
Thu, 09/8/16 - 09:50 am
FDA
clinical trials
cabozantinib
Cobimetinib
Exelixis
Medivation
Xtandi
Celldex Therapeutics
glemba
Palatin
bremelanotide
CRLX101
Cerulean Pharma
Anthera Pharmaceuticals
Following another PhII failure, cash-strapped Cerulean chops half its staff
Endpoints
Fri, 08/19/16 - 11:30 am
Cerulean Pharma
clinical trials
layoffs
CRLX101
Here are 13 MA cancer biotechs hoping to make waves next month
Bizjournals.com
Fri, 05/20/16 - 11:36 am
Boston
biotech
ASCO 2016
Ariad Pharmaceuticals
Immunogen
Ziopharm
Vertex Pharmaceuticals
Tokai
Infinity Pharmaceuticals
Momenta
Merrimack
Tesaro
Syndax
Kyropharm
Foundation Medicine
Cerulean Pharma
7 Biotech Stocks Moving Off The UBS Healthcare Conference
Yahoo/Benzinga
Tue, 05/19/15 - 04:57 pm
biotech
UBS
AcelRx
Affirmed NV
Atara
Cerulean Pharma
Endo International
Esperion Therapeutics
Immune Design
IPO Preview: Cerulean Pharma
Seeking Alpha
Thu, 04/10/14 - 07:44 am
IPOs
Cerulean Pharma